Oprega-M Tablet SR
Marketer
Orama Life Sciences Private Limited
Salt Composition
Methylcobalamin (1500mcg) + Pregabalin (75mg)
Overview Oprega-M Tablet SR
Oprega-M SR tablets are a prescription medication for managing neuropathic pain. They reduce pain sensations by regulating calcium channel function within nerve cells. This medication also safeguards nerve fibers and promotes the repair of damaged nerve cells. Oprega-M SR tablets are administered orally, with or without food, ideally before sleep. Consistent daily timing helps maintain stable drug levels. Follow your doctor's prescribed dosage and duration precisely, as this medication can be habit-forming. If a dose is missed, take it immediately upon recollection. Complete the entire treatment course, even with symptom improvement. Abrupt cessation should be avoided without consulting your physician. Common side effects may include nasal congestion, increased hunger, elevated mood, shaking, visual blurring, dry mouth, lightheadedness, and drowsiness. Refrain from driving or activities demanding concentration until the medication's effects are understood. Side effects are typically mild and subside over time. Weight gain is a potential effect; regular exercise and a healthy diet can help mitigate this. Report any unusual mood or behavioral shifts, new or worsening depression, or suicidal ideation to your doctor immediately. Disclose all other medications you're using, as interactions may reduce Oprega-M SR's efficacy or alter its action. Inform your doctor of pregnancy, pregnancy plans, or breastfeeding.
Uses of Oprega-M Tablet SR
Managing neuropathic pain
Major Benefits of Oprega-M Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Oprega-M Tablet SR whole; avoid chewing, crushing, or fracturing it. This medication can be consumed with or without food, but consistent timing is recommended.
Common Side effects of Oprega-M Tablet SR:
- Sleepiness
- Dizziness
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Increased appetite
- Blurred vision
- Constipation
- Muscle cramp
- Edema (swelling)
- Erectile dysfunction
- Weight gain
- Balance disorder (loss of balance)
- Lethargy
- Vertigo
- Vomiting
- Headache
- Confusion
- Disorientation
- Abnormality of voluntary movements
How to use Oprega-M Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Oprega-M Tablet SR whole; avoid chewing, crushing, or breaking it. While this medication can be taken with or without food, consistent timing is recommended for optimal results.
How Oprega-M Tablet SR works:
Oprega-M SR tablets contain methylcobalamin and pregabalin, working synergistically to alleviate neuropathic pain. Methylcobalamin, a B vitamin variant, supports myelin production—the protective sheath around nerve fibers—promoting nerve cell repair. Pregabalin, an alpha-2-delta ligand, reduces pain signals by regulating calcium influx within nerve cells. This combined action provides effective relief from nerve damage-related pain.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Oprega-M extended-release tablets and alcohol may result in significant somnolence.
PregnancyCONSULT YOUR DOCTOR
The extended-release Oprega-M tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Prolonged-release Oprega-M tablets pose a likely risk during lactation. Available evidence from human studies indicates potential transfer to breast milk, possibly endangering the infant.
DrivingUNSAFE
Taking Oprega-M Extended-Release tablets might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Driving should be avoided if these side effects appear.
KidneyCAUTION
Individuals with kidney impairment should use Oprega-M Tablet SR cautiously. The Oprega-M Tablet SR dosage might require modification. A physician's consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Oprega-M Tablet SR in patients with liver disease appears to pose minimal risk. Current evidence indicates dose modification may not be necessary, though further information is limited. Physician consultation is advised.
What if you forget to take Oprega-M Tablet SR :
Should you forget to take your Oprega-M Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Oprega-M Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |



